Molecular Cancer,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: Sept. 7, 2024
Cancer-associated
fibroblasts
(CAFs)
are
a
diverse
stromal
cell
population
within
the
tumour
microenvironment,
where
they
play
fundamental
roles
in
cancer
progression
and
patient
prognosis.
Multiple
lines
of
evidence
have
identified
that
CAFs
critically
involved
shaping
structure
function
microenvironment
with
numerous
functions
regulating
behaviours,
such
as
metastasis,
invasion,
epithelial-mesenchymal
transition
(EMT).
can
interact
extensively
cells
by
producing
extracellular
vesicles
(EVs),
multiple
secreted
factors,
metabolites.
Notably,
CAF-derived
EVs
been
critical
mediators
therapy
resistance,
constitute
novel
targets
biomarkers
management.
This
review
aimed
to
summarize
biological
detailed
molecular
mechanisms
mediating
resistance
chemotherapy,
targeted
agents,
radiotherapy,
immunotherapy.
We
also
discussed
therapeutic
potential
clinical
management,
thereby
providing
strategy
for
enhancing
efficacy
improving
Cancers,
Journal Year:
2023,
Volume and Issue:
15(2), P. 335 - 335
Published: Jan. 4, 2023
Lung
cancer
is
the
most
frequently
diagnosed
and
leading
cause
of
death
worldwide.
The
common
lung
non-small
cell
(NSCLC),
with
an
overall
5-year
survival
rate
around
20%
because
NSCLC
a
metastatic
disease.
A
better
understanding
mechanism
underlying
metastasis
therefore
urgently
needed.
tumor
microenvironment
involves
different
types
stromal
cells
functions
as
key
components
in
progression
NSCLC.
Through
epithelial–mesenchymal
transition
(EMT),
which
epithelial
lose
their
polarity
acquire
mesenchymal
potential,
abilities,
well
stem-cell-like
potential.
We
previously
reported
that
cancer-associated
fibroblasts
(CAFs)
interact
to
allow
for
acquisition
malignancy
treatment
resistance
by
paracrine
loops
via
EMT
signals
microenvironment.
Furthermore,
CAFs
regulate
cytotoxic
activity
immune
various
cytokines
chemokines,
creating
tolerance.
Regulation
can
affect
responses.
Recent
research
has
shown
several
roles
tumorigenesis,
owing
heterogeneity,
so
molecular
markers
should
be
elucidated
classify
tumor-promoting
subtypes
facilitate
establishment
CAF-specific
targeted
therapies.
CAF-targeted
treatments
may
suppress
niche
stem
immunosuppressive
network
thus
prove
useful
through
multiple
mechanisms.
Frontiers in Oncology,
Journal Year:
2024,
Volume and Issue:
14
Published: Feb. 23, 2024
Gastrointestinal
(GI)
tumors
are
a
significant
global
health
threat,
with
high
rates
of
morbidity
and
mortality.
Exosomes
contain
various
biologically
active
molecules
like
nucleic
acids,
proteins,
lipids
can
serve
as
messengers
for
intercellular
communication.
They
play
critical
roles
in
the
exchange
information
between
tumor
cells
microenvironment
(TME).
The
TME
consists
mesenchymal
components
extracellular
matrix
(ECM),
fibroblasts
being
most
abundant
cell
type
mesenchyme.
Cancer-associated
(CAFs)
derived
from
normal
stem
that
activated
TME.
CAFs
secrete
exosomes
to
modulate
proliferation,
invasion,
migration,
drug
resistance,
other
biological
processes
tumors.
Additionally,
manipulate
function
behavior
through
direct
cell-cell
interactions.
This
review
provides
summary
crosstalk
GI
exosomes,
along
potential
underlying
mechanisms.
Molecular Cancer,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: Sept. 7, 2024
Cancer-associated
fibroblasts
(CAFs)
are
a
diverse
stromal
cell
population
within
the
tumour
microenvironment,
where
they
play
fundamental
roles
in
cancer
progression
and
patient
prognosis.
Multiple
lines
of
evidence
have
identified
that
CAFs
critically
involved
shaping
structure
function
microenvironment
with
numerous
functions
regulating
behaviours,
such
as
metastasis,
invasion,
epithelial-mesenchymal
transition
(EMT).
can
interact
extensively
cells
by
producing
extracellular
vesicles
(EVs),
multiple
secreted
factors,
metabolites.
Notably,
CAF-derived
EVs
been
critical
mediators
therapy
resistance,
constitute
novel
targets
biomarkers
management.
This
review
aimed
to
summarize
biological
detailed
molecular
mechanisms
mediating
resistance
chemotherapy,
targeted
agents,
radiotherapy,
immunotherapy.
We
also
discussed
therapeutic
potential
clinical
management,
thereby
providing
strategy
for
enhancing
efficacy
improving